29 cases of intraperitoneal hyperthermic perfusion in the treatment of advanced gastric cancer experience.docVIP

 PAGE \* MERGEFORMAT 8 29 cases of intraperitoneal hyperthermic perfusion in the treatment of advanced gastric cancer experience [Keywords:] intraperitoneal hyperthermic perfusion for advanced gastric cancer Stomach cancer is the higher incidence of malignant tumors in China, one of the current operation is still the main treatment, coupled with postoperative chemotherapy and radiotherapy. Despite the recent growing awareness of cancer, but still on the technique recurrence and metastasis after the formation of effective prevention and treatment is difficult, the survival rate after 5 years is not ideal. now I Branch in 2003-2005 were treated with advanced gastric cancer patients in the clinical treatment of 29 cases are summarized as follows. 1 Clinical data Our department in 2003-2005 were treated in 29 patients with advanced gastric cancer, including invasive muscle without a breakthrough to the slurry for 18 cases, invasion to the muscle and has been a breakthrough in plasma of 11 patients. Myometrial invasion to the pulp without breaking the 18 cases included: 10 cases of mucinous adenocarcinoma, tubular adenocarcinoma in 6 cases, 1 case of signet ring cell carcinoma, squamous cell carcinoma, 1 case of gastric cancer patients to be OK. Which cut off the edge of the stomach, the intraoperative rapid pathological examination revealed a tumor cell margin were 6 cases (4 cases of mucinous adenocarcinoma, tubular adenocarcinoma in 1 case, 1 case of signet ring cell carcinoma), extended resection immediately and cut off When the stomach to be fully protected geographical margins and tumor location. of surgery is not applied intraperitoneal hyperthermic perfusion therapy (IPHP). Myometrial invasion to the pulp and has been a breakthrough in the 11 cases, including: 4 cases of tubular adenocarcinoma, mucinous adenocarcinoma in 5 cases, 1 case of signet ring cell carcinoma, squamous cell carcinoma, 1 case of gastric cancer patients to be OK. Which